| 1 |
Guger M, Hatschenberger R, Leutmezer F. Non-interventional, prospective, observational study on spasticity-associated symptom control with nabiximols as add-on therapy in patients with multiple sclerosis spasticity in Austria. Brain Behav 2023;:e2947. [PMID: 36934456 DOI: 10.1002/brb3.2947] [Reference Citation Analysis]
|
| 2 |
Fu Z, Zhao PY, Yang XP, Li H, Hu SD, Xu YX, Du XH. Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: A review. Front Pharmacol 2023;14:1094020. [PMID: 36755953 DOI: 10.3389/fphar.2023.1094020] [Reference Citation Analysis]
|
| 3 |
Uzair M, Qaiser H, Arshad M, Tahseen S, Bashir S. Neurobiology of Cannabinoids and Medical Cannabis in Therapeutic Intervention for Multiple Sclerosis. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases 2022. [DOI: 10.4018/978-1-6684-5652-1.ch008] [Reference Citation Analysis]
|
| 4 |
Shah D, Shah D, Mohamed Y, Rosas D, Moffitt A, Haynes TH, Cortes F, Neasman TB, Kathari PK, Villagran A, Zeine RR. Anti-Tumor Effects of Cannabinoids in Brain, Lung, Breast, Prostate, Colorectal, and Pancreatic Cancers. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases 2022. [DOI: 10.4018/978-1-6684-5652-1.ch005] [Reference Citation Analysis]
|
| 5 |
Pattabhiramaiah M, Mallikarjunaiah S. Medical Cannabis in the Treatment of Epilepsy. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases 2022. [DOI: 10.4018/978-1-6684-5652-1.ch004] [Reference Citation Analysis]
|
| 6 |
Komalasari R. History and Legislative Changes Governing Medical Cannabis in Indonesia. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases 2022. [DOI: 10.4018/978-1-6684-5652-1.ch012] [Reference Citation Analysis]
|
| 7 |
Acker CR, Zeine RR. Cannabinoid Efficacy for Developmental Epileptic Encephalopathy (DEE) Intractable Seizure Control. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases 2022. [DOI: 10.4018/978-1-6684-5652-1.ch003] [Reference Citation Analysis]
|
| 8 |
Vuic B, Milos T, Tudor L, Konjevod M, Nikolac Perkovic M, Jazvinscak Jembrek M, Nedic Erjavec G, Svob Strac D. Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential. Biomedicines 2022;10. [PMID: 36551756 DOI: 10.3390/biomedicines10123000] [Reference Citation Analysis]
|
| 9 |
Tudorancea IM, Ciorpac M, Stanciu GD, Caratașu C, Săcărescu A, Ignat B, Burlui A, Rezuș E, Creangă I, Alexa-Stratulat T, Tudorancea I, Tamba BI. The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases. Biomedicines 2022;10:2492. [PMID: 36289755 DOI: 10.3390/biomedicines10102492] [Reference Citation Analysis]
|
